M. Grioni

发表

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.

S. Bicciato, A. Salonia, A. Briganti, 2018, Cell reports.

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

Alessia Ricupito, Matteo Bellone, Veronica Huber, 2012, Cancer research.

Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer

M. Grioni, M. Bellone, Arianna Brevi, 2020, Frontiers in Immunology.

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy

A. Elia, A. Corti, F. Curnis, 2018, Clinical Cancer Research.

Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors.

V. Basso, A. Mondino, E. Degl'innocenti, 2010, Cancer research.

Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type‐2 cytotoxic T lymphocytes

E. Degl'innocenti, A. Camporeale, G. Iezzi, 2006, European journal of immunology.

Immune Responses 2 the Activity of Dendritic Cells Toward Type Type 2 Cytotoxic T Lymphocytes Modulate

E. Degl'innocenti, G. Iezzi, Andrea Boni, 2006 .

Type 2 Cytotoxic T Lymphocytes Modulate the Activity of Dendritic Cells Toward Type 2 Immune Responses1

E. Degl'innocenti, G. Iezzi, Andrea Boni, 2006, The Journal of Immunology.

Boosting anticancer vaccines

A. Calcinotto, M. Grioni, M. Bellone, 2013, Oncoimmunology.

iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells

M. Freschi, P. Dellabona, A. Calcinotto, 2010, PloS one.

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

A. Elia, M. Swartz, A. Corti, 2017, Cancer research.

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

G. Tonon, P. L. Bergsagel, E. Esplugues, 2018, Nature Communications.

Gene Signatures Distinguish Stage‐Specific Prostate Cancer Stem Cells Isolated From Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors

R. Galli, I. Piras, M. Freschi, 2013, Stem cells translational medicine.

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis

A. Elia, A. Briganti, R. Galli, 2020, Frontiers in Immunology.

Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer

F. Montorsi, A. Briganti, C. Doglioni, 2014, Oncogene.

Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings.

Renato Longhi, Alessia Ricupito, Matteo Bellone, 2013, Cancer research.

Targeting TNF-α to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy

A. Corti, F. Curnis, A. Mondino, 2012, The Journal of Immunology.

Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.

R. Galli, I. Piras, A. Bachi, 2015, Cancer research.

Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses

R. Galli, A. Mondino, M. Freschi, 2013, Oncoimmunology.

Vasculature‐targeted tumor necrosis factor‐alpha increases the therapeutic index of doxorubicin against prostate cancer

A. Corti, N. Greenberg, E. Degl'innocenti, 2008, The Prostate.

Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.

C. Doglioni, E. Degl'innocenti, M. Freschi, 2008, Cancer research.

Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD 4 + CD 25 + Regulatory T Cells

C. Doglioni, E. Degl'innocenti, M. Freschi, 2007 .

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma

G. Tonon, P. L. Bergsagel, E. Cattaneo, 2015, Oncoimmunology.

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

G. Tonon, P. L. Bergsagel, E. Esplugues, 2018, Nature Communications.

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis

M. Ferrari, A. Elia, A. Briganti, 2021, Science.

CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.

E. Cattaneo, P. Dellabona, M. Ponzoni, 2021, Blood advances.

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

R. Moresco, S. Valtorta, A. Coliva, 2021, Frontiers in Oncology.

Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization

N. Greenberg, C. Arcelloni, E. Degl'innocenti, 2005, European journal of immunology.

Microenvironment and Immunology Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-In fi ltrating T Lymphocytes

R. Canese, G. Parmiani, S. Fais, 2012 .

Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.

Matteo Bellone, A. Mondino, E. Degl'innocenti, 2003, Cancer research.

Modulators of arginine metabolism support cancer immunosurveillance

M. Freschi, G. Capuano, M. Grioni, 2009, BMC Immunology.

Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer

Alessia Ricupito, Matteo Bellone, M. Freschi, 2011, Clinical Cancer Research.